LONG COVID SYNDROME
Clinical trials for LONG COVID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LONG COVID SYNDROME trials appear
Sign up with your email to follow new studies for LONG COVID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug anktiva tested for long COVID relief
Disease control Recruiting nowThis study tests the safety of a drug called Anktiva in 40 adults with Long COVID—persistent symptoms after a COVID-19 infection. Participants receive the drug as a shot, and researchers monitor for side effects and changes in symptoms. The goal is to see if Anktiva is safe enoug…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could blood filtering ease long COVID? new trial aims to find out
Disease control Recruiting nowSome people with long COVID have harmful antibodies that may be attacking their own bodies, causing severe fatigue and other symptoms. This study tests a treatment called immunoadsorption, which filters the blood to remove those antibodies. About 70 participants will receive eith…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Taurine supplement tested as cheap fix for long COVID dizziness
Symptom relief Recruiting nowThis study tests whether taking taurine—a natural amino acid—for 12 weeks can improve blood vessel function and reduce dizziness when standing up in people with Long COVID. Researchers will measure blood flow, heart rate, and brain blood flow in 30 participants before and after s…
Matched conditions: LONG COVID SYNDROME
Sponsor: York University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Could a cancer drug ease long COVID? new trial aims to find out
Symptom relief Recruiting nowThis Phase 2 trial tests whether the drug plitidepsin can improve overall health in 90 adults with moderate-to-severe long COVID symptoms. Participants receive either plitidepsin or a placebo intravenously over four 3-day cycles, with a 90-day follow-up. The study is double-blind…
Matched conditions: LONG COVID SYNDROME
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Heart MRI breakthrough could spot hidden risks in thousands
Knowledge-focused Recruiting nowThis study is testing whether a detailed heart MRI (called T1 mapping) can better predict who will develop heart disease, heart failure, or long COVID complications. Researchers will scan 6000 adults without known heart disease and follow them over time. The goal is to see if sub…
Matched conditions: LONG COVID SYNDROME
Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC